Jiashuo Chao
- Topics
- Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers)Cancer Mechanisms and Therapy (5 papers)Hepatocellular Carcinoma Treatment and Prognosis (5 papers)
- Cited by
- HepatologyOncologyCancer Research
- Journals
- Nature CommunicationsScientific ReportsInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- ChinaUnited States
In The Last Decade
Jiashuo Chao
19 papers receiving 255 citations
Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 116
- Molecular Biology 74
- Hepatology 67
- Surgery 60
- Pulmonary and Respiratory Medicine 45
Countries citing papers authored by Jiashuo Chao
This map shows the geographic impact of Jiashuo Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiashuo Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiashuo Chao more than expected).
Fields of papers citing papers by Jiashuo Chao
This network shows the impact of papers produced by Jiashuo Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiashuo Chao. The network helps show where Jiashuo Chao may publish in the future.
Co-authorship network of co-authors of Jiashuo Chao
This figure shows the co-authorship network connecting the top 25 collaborators of Jiashuo Chao. A scholar is included among the top collaborators of Jiashuo Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiashuo Chao. Jiashuo Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinomabreakdown → | 43 |
| 5 | 19 | |
| 6 | 41 | |
| 7 | 8 | |
| 8 | 14 | |
| 9 | 8 | |
| 10 | 15 | |
| 11 | 14 | |
| 12 | The efficacy and safety of bevacizumab as a salvage therapy for patients with advanced hepatocellular carcinoma targeting immune tolerance. | 2 |
| 13 | 19 | |
| 14 | 15 | |
| 15 | 4 | |
| 16 | Dedifferentiation of hepatocellular carcinoma: molecular mechanisms and therapeutic implications. | 31 |
| 17 | 4 | |
| 18 | 4 | |
| 19 | 8 | |
| 20 | 2 |
About Jiashuo Chao
Jiashuo Chao is a scholar working on Hepatology, Oncology and Pathology and Forensic Medicine, having authored 20 papers that have together received 255 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer Mechanisms and Therapy (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Hepatology (67 citations), Oncology (116 citations) and Cancer Research (41 citations). Jiashuo Chao has collaborated with scholars based in China and United States. Frequent co-authors include Hongcheng Sun, Haitao Zhao, Senlin Zhao, Xiaobo Yang, Ziyu Xun, Longhao Zhang, Nan Zhang, Yunchao Wang, Xinmu Zhang and Yanyu Wang. Their work appears in journals such as Nature Communications, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.